Your search returned 63 results.

Results
	1.	Reply to a. Avan et Al. MedStar authors: Swain, Sandra M PMID: 25870094 Year: 2015 Citation: Journal of Clinical Oncology. 33(15):1712, 2015 May 20. Institution: Washington Cancer Institute Medline publication type: Comment Letter Form of publication: Journal Article All authors: Baselga J, Clark E, Kiermaier A, Swain S DOI: http://dx.doi.org/10.1200/JCO.2015.60.8398 Add to cart (remove)
	2.	Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors: Swain, Sandra M PMID: 23602601 Year: 2013 Citation: Lancet Oncology. 14(6):461-71, 2013 May. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM DOI: http://dx.doi.org/10.1016/S1470-2045(13)70130-X Add to cart (remove)
	3.	Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. MedStar authors: Swain, Sandra M PMID: 22152853 Year: 2012 Citation: Lancet. 379(9814):432-44, 2012 Feb 4. Institution: Washington Cancer Institute Medline publication type: Comparative Study Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Albain K, Bergh J, Clarke M, Cutter D, Darby S, Davies C, Di Leo A, Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Godwin J, Gray R, McGale P, Pan HC, Peto R, Piccart M, Pritchard K, Swain S, Taylor C, Wang YC DOI: http://dx.doi.org/10.1016/S0140-6736(11)61625-5 Add to cart (remove)
	4.	Pazopanib for the treatment of breast cancer. [Review] MedStar authors: Swain, Sandra M PMID: 22233389 Year: 2012 Citation: Expert Opinion on Investigational Drugs. 21(2):217-25, 2012 Feb. Institution: Washington Cancer Institute Medline publication type: Journal Article Research Support, N.I.H., Extramural Review Form of publication: Journal Article All authors: Amiri-Kordestani L, Swain SM, Tan AR DOI: http://dx.doi.org/10.1517/13543784.2012.652304 Add to cart (remove)
	5.	Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. MedStar authors: Swain, Sandra M PMID: 22393101 Year: 2012 Citation: Journal of Clinical Oncology. 30(12):1268-73, 2012 Apr 20. Institution: Washington Cancer Institute Medline publication type: Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Allred DC, Anderson SJ, Costantino JP, Geyer CE Jr, Julian TB, Land SR, Mamounas EP, Nagtegaal ID, Paik S, Swain SM, Wickerham DL, Wolmark N DOI: http://dx.doi.org/10.1200/JCO.2010.34.0141 Add to cart (remove)
	6.	Bevacizumab added to neoadjuvant chemotherapy for breast cancer. MedStar authors: Swain, Sandra M PMID: 22276821 Year: 2012 Citation: New England Journal of Medicine. 366(4):310-20, 2012 Jan 26. Institution: Washington Cancer Institute Medline publication type: Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Form of publication: Journal Article All authors: Adams PT, Atkins JN, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Mamounas EP, Margolese RG, Mehta RS, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA DOI: http://dx.doi.org/10.1056/NEJMoa1111097 Add to cart (remove)
	7.	Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial. MedStar authors: Swain, Sandra M PMID: 22704583 Year: 2012 Citation: Lancet Oncology. 13(7):734-42, 2012 Jul. Institution: Washington Cancer Institute Medline publication type: Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Anderson SJ, Baez-Diaz L, Brufsky AM, Costantino JP, Dakhil S, Falkson CI, Fehrenbacher L, Geyer CE Jr, Gralow JR, King KM, Lad T, Lembersky BC, Mamounas EP, Paterson AH, Perez EA, Robidoux A, Swain SM, Weir LM, Wolmark N, Zheng P DOI: http://dx.doi.org/10.1016/S1470-2045(12)70226-7 Add to cart (remove)
	8.	Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study. MedStar authors: Swain, Sandra M PMID: 23475636 Year: 2013 Citation: Oncologist. 18(3):257-64, 2013. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Amadori D, Baselga J, Benyunes MC, Clark E, Cortes J, Ewer MS, Knott A, Miles D, Ross G, Swain SM DOI: http://dx.doi.org/10.1634/theoncologist.2012-0448 Add to cart (remove)
	9.	Pertuzumab : evolving therapeutic strategies in the management of HER2-overexpressing breast cancer. [Review] MedStar authors: Swain, Sandra M PMID: 23530718 Year: 2013 Citation: Expert Opinion on Biological Therapy. 13(5):779-90, 2013 May. Institution: Washington Cancer Institute Medline publication type: Journal Article Research Support, Non-U.S. Gov't Review Form of publication: Journal Article All authors: O'Sullivan CC, Swain SM DOI: http://dx.doi.org/10.1517/14712598.2013.783007 Add to cart (remove)
	10.	Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. MedStar authors: Swain, Sandra M PMID: 24262440 Year: 2013 Citation: Journal of the National Cancer Institute. 105(23):1782-8, 2013 Dec 4. Institution: Washington Cancer Institute Medline publication type: Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Bandos H, Blackmon NL, Bohn OL, Burandt E, Costantino JP, Fehrenbacher L, Fumagalli D, Gavin PG, Geyer CE Jr, Goldstein LC, Horne ZD, Jeong JH, Kim C, Kim SI, Kim SR, Lee A, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Reilly ML, Remillard MY, Romond EH, Sneige N, Swain SM, Tanaka N, Taniyama Y, Wickerham DL, Wolmark N DOI: http://dx.doi.org/10.1093/jnci/djt321 Add to cart (remove)
	11.	Adjuvant trastuzumab: does time really matter?. MedStar authors: Swain, Sandra M PMID: 23624497 Year: 2013 Citation: Oncologist. 18(5):490-2, 2013. Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Swain SM DOI: http://dx.doi.org/10.1634/theoncologist.2013-0094 Add to cart (remove)
	12.	Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. MedStar authors: Swain, Sandra M PMID: 24095300 Year: 2013 Citation: Lancet Oncology. 14(12):1183-92, 2013 Nov. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky AM, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Margolese RG, Paik S, Rastogi P, Robidoux A, Sarwar S, Shibata HR, Swain SM, Tang G, Wolmark N DOI: http://dx.doi.org/10.1016/S1470-2045(13)70411-X Add to cart (remove)
	13.	Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial. MedStar authors: Swain, Sandra M PMID: 23940225 Year: 2013 Citation: Journal of Clinical Oncology. 31(26):3197-204, 2013 Sep 10. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Atkins JN, Azar CA, Biggs DD, Brufsky AM, Costantino JP, Donnellan PP, Fehrenbacher L, Geyer CE Jr, Levine EA, Mamounas EP, Northfelt DW, Paik S, Polikoff JA, Provencher L, Rastogi P, Robidoux A, Swain SM, Tang G, Wolmark N, Zapas JL DOI: http://dx.doi.org/10.1200/JCO.2012.48.1275 Add to cart (remove)
	14.	Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). MedStar authors: Swain, Sandra M PMID: 24129974 Year: 2013 Citation: Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Amadori D, Baselga J, Clark E, Knott A, Miles D, Ross G, Semiglazov V, Sunpaweravong P, Swain SM DOI: http://dx.doi.org/10.1007/s10549-013-2710-z Add to cart (remove)
	15.	Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 23868905 Year: 2013 Citation: Annals of Oncology. 24(10):2630-5, 2013 Oct. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM DOI: http://dx.doi.org/10.1093/annonc/mdt274 Add to cart (remove)
	16.	Reply to E.J. Moylan et al. MedStar authors: Swain, Sandra M PMID: 24419136 Year: 2014 Citation: Journal of Clinical Oncology. 32(6):606-7, 2014 Feb 20. Institution: Washington Cancer Institute Medline publication type: Comment Letter Form of publication: Journal Article All authors: Geyer CE Jr, Swain SM, Tang G DOI: http://dx.doi.org/10.1200/JCO.2013.53.8744 Add to cart (remove)
	17.	Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel. MedStar authors: Swain, Sandra M PMID: 23969513 Year: 2013 Citation: Anti-Cancer Drugs. 24(10):1084-92, 2013 Nov. Institution: Washington Cancer Institute Medline publication type: Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Brewster M, Cortes J, Garg A, Grincuka E, Hauschild M, Kudaba I, Lum BL, Marier JF, Masuda N, McNally V, Nijem I, Patel T, Ross G, Swain SM, Trinh MM, Visich J DOI: http://dx.doi.org/10.1097/CAD.0000000000000016 Add to cart (remove)
	18.	Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 25332247 Year: 2014 Citation: Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM DOI: http://dx.doi.org/10.1200/JCO.2013.54.5384 Add to cart (remove)
	19.	Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA. MedStar authors: Swain, Sandra M PMID: 24685829 Year: 2014 Citation: Annals of Oncology. 25(6):1116-21, 2014 Jun. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Cortes J, Im YH, Lee LF, Miles D, Quah C, Swain SM DOI: http://dx.doi.org/10.1093/annonc/mdu133 Add to cart (remove)
	20.	Pertuzumab for the treatment of breast cancer. [Review] MedStar authors: Lynce, Filipa Swain, Sandra M PMID: 24921704 Year: 2014 Citation: Cancer Investigation. 32(8):430-8, 2014 Oct. Institution: Washington Cancer Institute Medline publication type: Journal Article Research Support, Non-U.S. Gov't Review Form of publication: Journal Article All authors: Lynce F, Swain SM DOI: http://dx.doi.org/10.3109/07357907.2014.922570 Add to cart (remove)
	21.	The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 24885258 Year: 2014 Citation: BMC Cancer. 14:307, 2014. Institution: Washington Cancer Institute Medline publication type: Clinical Trial Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Beattie M, Hurvitz S, Jahanzeb M, Kaufman PA, Lai C, Masaquel A, Mason G, O'Shaughnessy J, Rugo HS, Swain S, Tripathy D, Yoo B DOI: http://dx.doi.org/10.1186/1471-2407-14-307 Add to cart (remove)
	22.	Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 25693012 Year: 2015 Citation: New England Journal of Medicine. 372(8):724-34, 2015 Feb 19. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, CLEOPATRA Study Group, Cortes J, Ferrero JM, Heeson S, Kim SB, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM DOI: http://dx.doi.org/10.1056/NEJMoa1413513 Add to cart (remove)
	23.	Treatment of HER2-positive metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 25970056 Year: 2015 Citation: New England Journal of Medicine. 372(20):1964-5, 2015 May 14. Institution: Washington Cancer Institute Medline publication type: Comment Letter Form of publication: Journal Article All authors: Baselga J, Clark E, Swain SM DOI: http://dx.doi.org/10.1056/NEJMc1503446 Add to cart (remove)
	24.	Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA. MedStar authors: Swain, Sandra M PMID: 24869931 Year: 2014 Citation: Oncologist. 19(7):693-701, 2014 Jul. Institution: Washington Cancer Institute Form of publication: Journal Article All authors: Baselga J, Chan V, Clark E, Im SA, Im YH, Knott A, Miles D, Ross G, Swain SM DOI: http://dx.doi.org/10.1634/theoncologist.2014-0033 Add to cart (remove)
	25.	Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial. MedStar authors: Swain, Sandra M PMID: 25559813 Year: 2015 Citation: Journal of Clinical Oncology. 33(12):1340-7, 2015 Apr 20. Institution: Washington Cancer Institute Medline publication type: Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Blackmon NL, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Kim SR, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N DOI: http://dx.doi.org/10.1200/JCO.2014.56.2439 Add to cart (remove)
	26.	Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study. [] MedStar authors: Swain, Sandra M PMID: 25542269 Year: 2015 Citation: Breast Cancer Research & Treatment. 149(1):163-9, 2015 Jan. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase II Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Bhatt K, Bury MJ, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Goel R, Jacobs SA, Johannes H, Julian TB, Mamounas EP, Provencher L, Rastogi P, Robidoux A, Stella PJ, Swain SM, Tan AR, Thirlwell MP, Wolmark N DOI: http://dx.doi.org/10.1007/s10549-014-3221-2 Add to cart (remove)
	27.	Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831. MedStar authors: Swain, Sandra M PMID: 25332249 Year: 2014 Citation: Journal of Clinical Oncology. 32(33):3744-52, 2014 Nov 20. Institution: Washington Cancer Institute Medline publication type: Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Colon-Otero G, Davidson NE, Geyer CE Jr, Gralow J, Jeong JH, Mamounas E, Martino S, Perez EA, Rastogi P, Romond EH, Sledge G, Suman VJ, Swain SM, Winer EP, Wolmark N, Zujewski JA DOI: http://dx.doi.org/10.1200/JCO.2014.55.5730 Add to cart (remove)
	28.	Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. MedStar authors: Swain, Sandra M PMID: 26272770 Year: 2015 Citation: Lancet Oncology. 16(9):1037-48, 2015 Sep. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Liu Q, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA DOI: http://dx.doi.org/10.1016/S1470-2045(15)00041-8 Add to cart (remove)
	29.	Acquired von Willebrand disease and multiple myeloma: a case report of a breast cancer survivor. MedStar authors: Jin, Ning Nesbitt, John A Salahuddin, Farah F PMID: 24911454 Year: 2014 Citation: Blood Coagul Fibrinolysis. 25(8):890-3, 2014 Dec. Blood Coagulation & Fibrinolysis. 25(8):890-3, 2014 Dec. Institution: MedStar Union Memorial Hospital Department: Medicine Medline publication type: Case Reports Journal Article Form of publication: Journal Article All authors: Jin N, Nesbitt JA, Salahuddin FF DOI: http://dx.doi.org/10.1097/MBC.0000000000000149 Add to cart (remove)
	30.	The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. MedStar authors: Swain, Sandra M PMID: 26759246 Year: 2016 Citation: Breast Cancer Research & Treatment. 155(2):235-51, 2016 Jan. Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Amiri-Kordestani L, Chavez KJ, Conway CM, Dine JL, Greer YE, Hewitt SM, Lipkowitz S, Merchant AS, O'Sullivan CC, Sinclair S, Steinberg SM, Stone B, Swain SM, Voeller D Add to cart (remove)
	31.	Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines. MedStar authors: Asch, Federico M Barac, Ana Herbolsheimer, Pia M Lynce, Filipa Mete, Mihriye Nunes, Raquel Shara, Nawar M Swain, Sandra M Wray, Lynette PMID: 26749359 Year: 2016 Citation: Breast Cancer Research & Treatment. 155(2):285-93, 2016 Jan. Institution: MedStar Health Research Institute MedStar Health Research Institute MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Washington Cancer Institute Washington Cancer Institute Washington Cancer Institute A Washington Cancer Instituteia Department: MedStar Heart Institute MedStar Heart Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Asch FM, Barac A, Herbolsheimer P, Isaacs C, Lynce F, Mete M, Nardacci MP, Nunes RA, Peshkin BN, Shara NM, Smith KL, Swain SM, Warren R, Wray L Add to cart (remove)
	32.	Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38. MedStar authors: Swain, Sandra M PMID: 26545405 Year: 2016 Citation: Cancer Epidemiology, Biomarkers & Prevention. 25(1):51-9, 2016 Jan. Institution: Washington Cancer Institute Medline publication type: Journal Article Multicenter Study Randomized Controlled Trial Form of publication: Journal Article All authors: Anderson SJ, Cecchini RS, Costantino JP, Geyer CE Jr, Jeong JH, Lembersky BC, Paterson AH, Rastogi P, Romond EH, Swain SM, Tang G, Wolmark N DOI: http://dx.doi.org/10.1158/1055-9965.EPI-15-0334-T Add to cart (remove)
	33.	Cardiovascular Disease After Aromatase Inhibitor Use. MedStar authors: Barac, Ana PMID: 27100398 Year: 2016 Citation: JAMA Oncology. 2(12):1590-1597, 2016 Dec 01 Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Amundsen B, Avila C, Barac A, Chlebowski RT, Chung J, Haque R, Schottinger JE, Shi J, Xu X DOI: https://dx.doi.org/10.1001/jamaoncol.2016.0429 Add to cart (remove)
	34.	Pertuzumab for the treatment of breast cancer: a safety review. [Review] MedStar authors: Swain, Sandra M PMID: 26982349 Year: 2016 Citation: Expert Opinion on Drug Safety. 15(6):853-63, 2016 Jun Institution: Washington Cancer Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Gao J, Swain SM DOI: https://dx.doi.org/10.1517/14740338.2016.1167185 Add to cart (remove)
	35.	Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial. MedStar authors: Swain, Sandra M PMID: 27812689 Year: 2017 Citation: JAMA Oncology. 3(3):335-341, 2017 Mar 01 Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Form of publication: Journal Article All authors: Bandos H, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Johnson NL, Kim SR, Lipchik C, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N DOI: https://dx.doi.org/10.1001/jamaoncol.2016.4884 Add to cart (remove)
	36.	HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens. MedStar authors: Swain, Sandra M PMID: 27692565 Year: 2017 Citation: Clinical Breast Cancer. 17(1):76-78, 2017 Feb Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Gao JJ, Pohlmann PR, Swain SM, Tan M DOI: https://dx.doi.org/10.1016/j.clbc.2016.08.005 Add to cart (remove)
	37.	Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5. MedStar authors: Swain, Sandra M PMID: 27693116 Year: 2017 Citation: Clinical Breast Cancer. 17(1):48-54.e3, 2017 Feb Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Ansari B, Buyse ME, Conlin AK, Geyer CE Jr, Gross HM, Jacobs SA, Keogh GP, Lord RS, Mamounas EP, Mauquoi C, Patocskai EJ, Polikoff JA, Rastogi P, Robidoux A, Smith JW 2nd, Stella PJ, Swain SM, Wolmark N DOI: https://dx.doi.org/10.1016/j.clbc.2016.07.008 Add to cart (remove)
	38.	Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30. MedStar authors: McCarron, Edward C Swain, Sandra M PMID: 28954297 Year: 2018 Citation: Journal of the National Cancer Institute. 110(2), 2018 Feb 01 Institution: MedStar Franklin Square Medical Center Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Bandos H, Brufsky AM, Fehrenbacher L, Ganz PA, Julian TB, Margolese RG, McCarron EC, Melnikow J, Rivera DR, Sturtz K, Swain SM, Wade JL 3rd DOI: https://dx.doi.org/10.1093/jnci/djx162 Add to cart (remove)
	39.	The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study. MedStar authors: Howard, Barbara V PMID: 29063981 Year: 2018 Citation: Breast Cancer Research & Treatment. 167(3):741-749, 2018 02. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Beebe-Dimmer JL, Bock CH, Cote ML, Desai P, Dyson G, Hou L, Howard BV, Jay AM, Prentice R, Purrington K, Simon MS DOI: https://dx.doi.org/10.1007/s10549-017-4521-0 Add to cart (remove)
	40.	Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials. MedStar authors: Blackburn, Matthew J Lynce, Filipa PMID: 29119354 Year: 2018 Citation: Breast Cancer Research & Treatment. 168(1):35-41, 2018 Feb. Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Hematology and Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Blackburn MJ, Cai L, Harris P, Isaacs C, Lynce F, Pohlmann PR, Rubinstein L, Wang H DOI: https://dx.doi.org/10.1007/s10549-017-4563-3 Add to cart (remove)
	41.	Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2. MedStar authors: Swain, Sandra M Zapas, John L PMID: 29072977 Year: 2017 Citation: Journal of Clinical Oncology. 35(35):3942-3948, 2017 Dec 10 Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Atkins JN, Biggs DD, Brufsky AM, Cecchini RS, Fehrenbacher L, Flynn PJ, Ganz PA, Geyer CE Jr, Gross HM, Jeong JH, Mamounas EP, Polikoff J, Rastogi P, Romond EH, Seay TE, Swain SM, Wade JL 3rd, Wahl TA, Wolmark N, Zapas JL DOI: https://dx.doi.org/10.1200/JCO.2017.74.1165 Add to cart (remove)
	42.	SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors: Asch, Federico M Barac, Ana Lynce, Filipa Swain, Sandra M PMID: 28314836 Year: 2017 Citation: Oncologist. 22(5):518-525, 2017 May Institution: MedStar Heart & Vascular Institute Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT DOI: https://dx.doi.org/10.1634/theoncologist.2016-0412 Add to cart (remove)
	43.	The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40. MedStar authors: Swain, Sandra M PMID: 27864694 Year: 2016 Citation: Annals of Surgical Oncology. 24(7):1853-1860, 2017 Jul Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Kidwell KM, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA, Zoon CK DOI: https://dx.doi.org/10.1245/s10434-016-5662-9 Add to cart (remove)
	44.	Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial. MedStar authors: McCarron, Edward C PMID: 30509771 Year: 2019 Citation: Lancet Oncology. 20(1):88-99, 2019 01. Institution: MedStar Franklin Square Medical Center Medline publication type: Journal Article Form of publication: Journal Article All authors: Bandos H, Brufsky AM, Chia SK, Dakhil SR, Fehrenbacher L, Geyer CE Jr, Graham ML, Jeong JH, Lembersky BC, Mamounas EP, McCarron EC, Paik S, Rastogi P, Seay TE, Soori GS, Swain SM, Wade JL 3rd, Walshe JM, Wickerham DL, Wolmark N DOI: https://dx.doi.org/10.1016/S1470-2045(18)30621-1 Add to cart (remove)
	45.	Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors. MedStar authors: Barac, Ana PMID: 30659431 Year: 2019 Citation: Breast Cancer Research & Treatment. 174(3):785-794, 2019 Apr. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Barac A, Chlebowski RT, Haque R, Shi J, Xu X DOI: https://dx.doi.org/10.1007/s10549-018-05086-8 Add to cart (remove)
	46.	Neoadjuvant Chemotherapy and Nipple-Sparing Mastectomy: Timing and Postoperative Complications. MedStar authors: Dervishaj, Ornela A Tung, Shawndeep S PMID: 31123933 Year: 2019 Citation: Annals of Surgical Oncology. 26(9):2768-2772, 2019 Sep. Institution: MedStar Washington Hospital Center Department: Surgery/Plastic Surgery Medline publication type: Journal Article Form of publication: Journal Article All authors: Bartholomew AJ, Caragacianu DL, Dervishaj OA, Kerivan LT, Sosin M, Tousimis EA, Tung SS, Willey SC DOI: https://dx.doi.org/10.1245/s10434-019-07418-4 Add to cart (remove)
	47.	Physician Perspectives on Fertility Preservation Discussions with Premenopausal Breast Cancer Patients: Results from a Multihospital Health Care System. MedStar authors: Bozzuto, Laura M Haslinger, Michelle Thibodeau, Renee Tsiapali, Ekaterini V Tung, Shawndeep S PMID: 31342399 Year: 2019 Citation: Annals of Surgical Oncology. 2019 Jul 24 Institution: MedStar Washington Hospital Center Department: Surgery/Plastic Surgery Medline publication type: Journal Article Form of publication: Journal Article All authors: Bartholomew AJ, Bozzuto LM, Haslinger M, Masciello MC, Thibodeau R, Tsiapali EV, Tung SS DOI: https://dx.doi.org/10.1245/s10434-019-07563-w Add to cart (remove)
	48.	Trastuzumab-Induced Cardiomyopathy. [Review] MedStar authors: Barac, Ana Gates, Emily PMID: 31587782 Year: 2019 Citation: Cardiology Clinics. 37(4):407-418, 2019 Nov. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Barac A, Barish R, Gates E DOI: https://dx.doi.org/10.1016/j.ccl.2019.07.005 Add to cart (remove)
	49.	The Role of Angiotensin-Converting Enzyme Inhibitors and beta-Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients. [Review] MedStar authors: Barac, Ana PMID: 31960742 Year: 2020 Citation: Journal of the American Heart Association. 9(2):e015327, 2020 01 21. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Barac A, Brown SA, Okwuosa TM, Volgman AS DOI: https://dx.doi.org/10.1161/JAHA.119.015327 https://dx.doi.org/10.1161/JAHA.119.015327 https://dx.doi.org/10.1161/JAHA.119.015327 https://dx.doi.org/10.1161/JAHA.119.015327 Add to cart (remove)
	50.	Intermittent left bundle branch block and acute heart failure in trastuzumab-induced cardiotoxicity. MedStar authors: Masson, Ravi PMID: 32723779 Year: 2020 Citation: BMJ Case Reports. 13(7), 2020 Jul 28. Institution: MedStar Washington Hospital Center Department: Medicine/Internal Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Bakhshi H, Haddad TM, Masson R DOI: https://dx.doi.org/10.1136/bcr-2020-236009 Add to cart (remove)
	51.	NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response. MedStar authors: Swain, Sandra M PMID: 32371537 Year: 2020 Citation: Clinical Cancer Research. 26(16):4233-4241, 2020 08 15. Institution: MedStar Health Department: Associate Dean for Research Development Medline publication type: Journal Article Form of publication: Journal Article All authors: Bandos H, Brauer HA, Geyer CE Jr, Goerlitz DS, Harris BT, Lucas PC, Mamounas EP, Rastogi P, Ren Y, Robidoux A, Swain SM, Tang G, Wolmark N DOI: https://dx.doi.org/10.1158/1078-0432.CCR-20-0152 Add to cart (remove)
	52.	Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer. MedStar authors: Blackburn, Matthew J Chitalia, Ami Dilawari, Asma Gallagher, Christopher Lynce, Filipa Mohebtash, Mahsa Tiwari, Shruti R PMID: 34157782 Year: 2021 Citation: Cancer. 127(19):3622-3630, 2021 10 01. Institution: MedStar Franklin Square Cancer Center at Loch Raven Campus MedStar Washington Hospital Center Washington Cancer Institute Department: Hematology & Oncology Fellowship Hematology and Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Abu-Khalaf M, Blackburn MJ, Chitalia A, Dilawari A, Gallagher C, Hahn OM, Isaacs C, Lynce F, Mohebtash M, Pohlmann PR, Shajahan-Haq AN, Tan M, Tiwari SR, Warren R, Wu T, Zhuo R DOI: https://dx.doi.org/10.1002/cncr.33620 Add to cart (remove)
	53.	Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study. MedStar authors: Swain, Sandra M PMID: 34890214 Year: 2022 Citation: Journal of Clinical Oncology. 40(5):438-448, 2022 02 10. Department: Associate Dean for Research Development Medline publication type: Journal Article Form of publication: Journal Article All authors: Barrios C, Bonnefoi H, Boulet T, De Laurentiis M, Ellis PA, Fehrenbacher L, Gianni L, Gralow J, Harbeck N, Huang CS, Im SA, Im YH, Ito Y, Krop IE, Liu H, Macharia H, Nowecki Z, Shah J, Song C, Swain SM, Toi M, Trask P, Winer EP DOI: https://dx.doi.org/10.1200/JCO.21.00896 Add to cart (remove)
	54.	Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. MedStar authors: Asch, Federico M Barac, Ana Cunningham, A Gallagher, Christopher Hofmeyer, Mark Srichai, M B Swain, Sandra M PMID: 30852761 Year: 2019 Citation: Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun. Institution: MedStar Health MedStar Health Research Institute MedStar Heart & Vascular Institute Washington Cancer Institute Department: Associate Dean for Research Development Medline publication type: Journal Article Form of publication: Journal Article All authors: Asch FM, Barac A, Cunningham A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Lynce F, Nunes R, Pohlmann PR, Shajahan-Haq A, Smith KL, Srichai MB, Swain SM, Tan MT, Timothee P, Warren R, Yu AF DOI: https://dx.doi.org/10.1007/s10549-019-05191-2 Add to cart (remove)
	55.	Bacitracin for Injection Recall: Impact on Immediate Breast Implant Surgical Outcomes. MedStar authors: Bekeny, Jenna Fan, Kenneth L Tefera, Eshetu A PMID: 36105366 Year: 2022 Citation: Breast Journal. 2022:1389539, 2022. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: MedStar Georgetown University Hospital/MedStar Washington Hospital Center Plastic Surgery Residency Surgery/Plastic Surgery Medline publication type: Journal Article Form of publication: Journal Article All authors: Bekeny JC, Fan KL, Song DH, Tefera EA, Tirrell AR DOI: https://dx.doi.org/10.1155/2022/1389539 Add to cart (remove)
	56.	Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC. MedStar authors: Gallagher, Christopher Lynce, Filipa Ottaviano, Yvonne PMID: 34400413 Year: 2021 Citation: Clinical Cancer Research. 27(21):5810-5817, 2021 11 01. Institution: MedStar Franklin Square Medical Center Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Althouse SK, Ballinger TJ, Bauchle A, Dong Z, Gallagher C, Liu JY, Lynce F, Masters AR, Miller KD, Ottaviano YL, Perkins SM, Sardesai SD, Schneider BP, Storniolo AM, Stratford RE Jr, Thomas A, Zhang JT DOI: https://dx.doi.org/10.1158/1078-0432.CCR-21-0493 Add to cart (remove)
	57.	Avastin withdrawal symptoms. MedStar authors: Lynce, Filipa Swain, Sandra M PMID: 22263961 Citation: Expert Opinion on Pharmacotherapy. 13(3):293-8, 2012 Feb. Institution: Washington Cancer Institute Medline publication type: Editorial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Lynce F, Swain SM DOI: http://dx.doi.org/10.1517/14656566.2012.652088 Add to cart (remove)
	58.	Pertuzumab: increasing the options. MedStar authors: Nunes, Raquel Swain, Sandra M PMID: 24855727 Citation: Oncology (Williston Park). 28(3):199, 204, 210, 2014 Mar. Institution: Washington Cancer Institute Medline publication type: Comment Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Nunes R, Swain SM Add to cart (remove)
	59.	Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Using US Electronic Health Records. MedStar authors: Swain, Sandra M PMID: 37167571 Year: 2023 Citation: JCO Oncology Practice. 19(7):435-445, 2023 07. Institution: Associate Dean for Research Development MedStar Health Medline publication type: Journal Article Form of publication: Journal Article All authors: Dang CT, Du Toit Y, Hurvitz SA, Knott A, Polito L, Restuccia E, Sanglier T, Shim J, Swain SM DOI: https://dx.doi.org/10.1200/OP.22.00565 Add to cart (remove)
	60.	Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. MedStar authors: McCarron, Edward C PMID: 38301187 Year: 2024 Citation: Journal of Clinical Oncology. 42(11):1288-1300, 2024 Apr 10. Institution: MedStar Franklin Square Medical Center Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Form of publication: Journal Article All authors: Ganz PA, Bandos H, Spanic T, Friedman S, Muller V, Kuemmel S, Delaloge S, Brain E, Toi M, Yamauchi H, de Duenas EM, Armstrong A, Im SA, Song CG, Zheng H, Sarosiek T, Sharma P, Geng C, Fu P, Rhiem K, Frauchiger-Heuer H, Wimberger P, t'Kint de Roodenbeke D, Liao N, Goodwin A, Chakiba-Brugere C, Friedlander M, Lee KS, Giacchetti S, Takano T, Henao-Carrasco F, Virani S, Valdes-Albini F, Domchek SM, Bane C, McCarron EC, Mita M, Rossi G, Rastogi P, Fielding A, Gelber RD, Scheepers ED, Cameron D, Garber J, Geyer CE, Tutt ANJ DOI: Click here to access online Add to cart (remove)
	61.	Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. MedStar authors: Chitalia, Ami Gallagher, Christopher Schlam, Ilana Swain, Sandra M Tiwari, Shruti PMID: 38538574 Year: 2024 Citation: Nature communications . 15(1):2691, 2024 Mar 27. Institution: Washington Cancer Institute Department: Associate Dean for Research Development MedStar Health Medline publication type: Clinical Trial, Phase II Journal Article Randomized Controlled Trial Form of publication: Journal Article All authors: Lynce F, Mainor C, Donahue RN, Geng X, Jones G, Schlam I, Wang H, Toney NJ, Jochems C, Schlom J, Zeck J, Gallagher C, Nanda R, Graham D, Stringer-Reasor EM, Denduluri N, Collins J, Chitalia A, Tiwari S, Nunes R, Kaltman R, Khoury K, Gatti-Mays M, Tarantino P, Tolaney SM, Swain SM, Pohlmann P, Parsons HA, Isaacs C DOI: https://dx.doi.org/10.1038/s41467-024-46961-x Add to cart (remove)
	62.	What Proportion of BRCA-Associated Breast Cancer Is Human Epidermal Growth Factor 2-Low and Eligible for Additional Targeted Therapy?. MedStar authors: Whitaker, Kristen PMID: 38776577 Year: 2024 Citation: Journal of Surgical Research. 299:217-223, 2024 Jul. Institution: MedStar Washington Hospital Center Department: Hematology/Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Forester E, Belsare A, Kim DW, Whitaker K, Obeid E, Goldstein LJ, Bleicher RJ, Daly MB, Williams AD DOI: https://dx.doi.org/10.1016/j.jss.2024.04.032 Add to cart (remove)
	63.	IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer. MedStar authors: Swain, Sandra M MedStar Health PMID: 38755096 Year: 2024 Citation: Annals of Oncology. 35(7):630-642, 2024 Jul. Department: Associate Dean for Research Development Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Form of publication: Journal Article All authors: Dent R, Andre F, Goncalves A, Martin M, Schmid P, Schutz F, Kummel S, Swain SM, Bilici A, Loirat D, Villalobos Valencia R, Im SA, Park YH, De Laurentis M, Colleoni M, Guarneri V, Bianchini G, Li H, Kirchmayer Machackova Z, Mouta J, Deurloo R, Gan X, Fan M, Mani A, Swat A, Cortes J DOI: https://dx.doi.org/10.1016/j.annonc.2024.04.001 Add to cart (remove)

Refine your search

Availability

Authors

Item types

Places

Topics

Your search returned 63 results.